HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Feng Shen Selected Research

Wei Feng Shen Research Topics

Disease

27Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 12/2006
23Type 2 Diabetes Mellitus (MODY)
11/2020 - 12/2006
18Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 06/2008
11Myocardial Infarction
01/2022 - 06/2008
10Atherosclerosis
01/2019 - 12/2006
9Pathologic Constriction (Stenosis)
01/2022 - 01/2009
8ST Elevation Myocardial Infarction
01/2020 - 06/2008
8Hypertension (High Blood Pressure)
11/2019 - 07/2007
8Inflammation (Inflammations)
11/2019 - 01/2016
5Stable Angina
12/2016 - 11/2013
5Thrombosis (Thrombus)
03/2015 - 01/2009
4Heart Failure
01/2021 - 04/2011
4Infarction (Infarctions)
03/2017 - 06/2008
4Atherosclerotic Plaque (Atheroma)
06/2016 - 06/2010
4Renal Insufficiency (Renal Failure)
07/2013 - 07/2007
3Death (Near-Death Experience)
01/2022 - 10/2012
3Diabetes Mellitus
10/2017 - 06/2011
3Hyperplasia
01/2017 - 05/2010
2Insulin Resistance
11/2019 - 01/2019
2Diabetes Complications
11/2019 - 07/2009
2Ischemia
12/2016 - 08/2011
2Fibrosis (Cirrhosis)
10/2016 - 04/2008
2Necrosis
06/2016 - 09/2012
2Acute Kidney Injury (Acute Renal Failure)
07/2013 - 11/2012
2Coronary Stenosis (Coronary Artery Stenosis)
07/2007 - 07/2007
1Stroke (Strokes)
01/2022
1Sclerosis
01/2020
1Systolic Heart Failure
12/2019
1Glucose Intolerance
01/2019
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2017
1Vascular System Injuries
12/2016
1Coronary Occlusion
03/2016

Drug/Important Bio-Agent (IBA)

13omega-Chloroacetophenone (Mace)IBA
01/2022 - 06/2008
12AlbuminsIBA
11/2018 - 12/2006
10Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2007
9C-Reactive ProteinIBA
01/2016 - 12/2006
8Receptor for Advanced Glycation End ProductsIBA
03/2017 - 10/2008
7Phenobarbital (Luminal)FDA Link
01/2020 - 07/2007
6Glycated Serum AlbuminIBA
11/2013 - 12/2006
5oxidized low density lipoproteinIBA
01/2019 - 03/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 07/2007
5Sirolimus (Rapamycin)FDA Link
10/2015 - 01/2009
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2013 - 01/2012
4Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2010
4HDL LipoproteinsIBA
12/2019 - 05/2015
4AdipokinesIBA
11/2019 - 01/2016
3Apolipoproteins E (ApoE)IBA
01/2019 - 06/2016
3CytokinesIBA
01/2019 - 01/2014
3HDL CholesterolIBA
01/2019 - 08/2009
3Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017 - 03/2013
3Tirofiban (Aggrastat)FDA Link
03/2015 - 06/2008
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2020 - 08/2010
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2019
2Aryldialkylphosphatase (Paraoxonase)IBA
12/2019 - 05/2015
2Cystatin CIBA
01/2018 - 01/2015
2Peptides (Polypeptides)IBA
12/2017 - 09/2012
2HMGB2 ProteinIBA
03/2017 - 01/2017
2vasostatin IIIBA
10/2016 - 09/2012
2Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2015 - 05/2013
2Platelet Membrane GlycoproteinsIBA
03/2015 - 06/2008
2Indicators and Reagents (Reagents)IBA
07/2013 - 01/2012
2Streptozocin (Streptozotocin)FDA Link
03/2013 - 05/2009
2Hemoglobins (Hemoglobin)IBA
01/2012 - 07/2009
2LigandsIBA
08/2011 - 08/2009
2Advanced Glycation End ProductsIBA
06/2011 - 07/2009
2HMGB1 Protein (HMG1)IBA
04/2011 - 08/2009
2Lipoprotein(a)IBA
10/2009 - 07/2007
2human esRAGE proteinIBA
10/2009 - 07/2009
1Chromogranin BIBA
01/2021
1AntioxidantsIBA
12/2019
1arylesteraseIBA
12/2019
1MicroRNAs (MicroRNA)IBA
11/2019
1SodiumIBA
11/2019
1CholesterolIBA
01/2019
1LDL CholesterolIBA
01/2019
1Triglycerides (Triacylglycerol)IBA
01/2019
1VimentinIBA
01/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
11/2018
1chemotactic factor inactivatorIBA
01/2018
1Apolipoproteins AIBA
10/2017
1apolipoprotein A-IV (apolipoprotein AIV)IBA
10/2017
1Member 3 Group A Nuclear Receptor Subfamily 4IBA
10/2017
1Lysine (L-Lysine)FDA Link
10/2017
1Glyoxal (Ethanedial)IBA
10/2017
1ApolipoproteinsIBA
10/2017
1Serum Amyloid A Protein (Serum Amyloid A)IBA
10/2017
1acetovanillone (apocynin)IBA
03/2017
1CyanatesIBA
12/2016
1homocitrullineIBA
12/2016
1Biological ProductsIBA
06/2016
1Lipoproteins (Lipoprotein)IBA
01/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2016

Therapy/Procedure

19Stents
01/2022 - 10/2008
16Percutaneous Coronary Intervention
11/2020 - 02/2007
4Drug-Eluting Stents
02/2017 - 02/2007
3Therapeutics
03/2015 - 06/2008
2Intraperitoneal Injections
01/2019 - 06/2016
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2016 - 02/2007
1Oral Administration
12/2016
1Endarterectomy (Thromboendarterectomy)
06/2016